
Constellation Brands (STZ) Stock Forecast & Price Target
Constellation Brands (STZ) Analyst Ratings
Bulls say
Constellation Brands is poised to continue its success as the largest provider of alcoholic beverages in the US, with limited international exposure. It has a strong portfolio of top-selling brands such as Corona and Modelo, and has a low risk investment in the growing cannabis industry. Despite company-specific headwinds, it has remained a market share gainer and its financials are projected to improve as it cycles through the current economic challenges.
Bears say
Constellation Brands is facing several headwinds, including challenges with the Hispanic consumer, weaker consumer sentiment, and macro pressures. Though the company has historically performed well and maintained strong brand health, these factors are causing a negative impact on their business. While there may be potential for upside from a potential reacceleration in the beer category and increased market share gains, it is important to note that Constellation Brands has limited revenue exposure to international markets and faces challenges with their wine and spirits business. As a result, the financial analyst has lowered their estimates for Constellation's revenue and earnings in the coming years. Additionally, the current valuation of the company is discounted, but there is potential for multiple expansion if there is a turnaround in performance and sentiment. The current guidance for FY27 is achievable, but there is potential downside risk if consumer sentiment deteriorates further. Overall, the analyst maintains a negative outlook for Constellation Brands and has a target price of $185, implying a 14.8x target multiple on FY28 EPS.
This aggregate rating is based on analysts' research of Constellation Brands and is not a guaranteed prediction by Public.com or investment advice.
Constellation Brands (STZ) Analyst Forecast & Price Prediction
Start investing in Constellation Brands (STZ)
Order type
Buy in
Order amount
Est. shares
0 shares